Avestria Ventures Fund II

Avestria Ventures

cb Email

Status

ACTIVE

Global HQ

San Francisco, United States

Countries of investment

United States

Investment stages

Pre-Seed
Seed

Industries

Women's Health
Life Sciences
Therapeutics
Diagnostics
Medical Devices
Digital Health

About
Avestria Ventures is a San Francisco-based venture capital firm focused on seeding women's health and female-led life science ventures. Their focus spans therapeutics, diagnostics, medical devices, and data-driven care across the United States, with offices in the San Francisco Bay Area and Beverly Hills. The firm supports female founders in healthcare from pre-seed through seed.

Min check size: $100K
Max check size: $5M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Avestria Ventures is a pre-seed to seed venture capital firm deploying capital across women's health and the life sciences. They invest in conditions affecting women exclusively, differently, or disproportionately, with a primary preference for female-led founding teams in healthcare and life science. The firm differentiates itself through a dual-arbitrage thesis, treating both women's healthcare and female life science founders as structurally overlooked and undervalued markets.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Founded in 2019 by Linda Greub (Managing Partner, healthcare VC veteran) and Tracy Warren (Managing Partner). Fund I ($10M) closed 2020. Focused on early-stage women's health innovations. Portfolio includes Bloomer Tech, MacroGenics, Aegle Therapeutics, Cognivue, EmpathyRx, and Turquoise Health.